Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-028336
Filing Date
2025-02-27
Accepted
2025-02-27 07:00:09
Documents
30
Period of Report
2025-02-27

Document Format Files

Seq Description Document Type Size
1 6-K imab_investor_present_2.htm 6-K 25793
2 EX-99.1 imab-ex99_1.htm EX-99.1 38056
3 GRAPHIC imab-ex99_1s1.jpg GRAPHIC 190460
4 GRAPHIC imab-ex99_1s2.jpg GRAPHIC 984532
5 GRAPHIC imab-ex99_1s3.jpg GRAPHIC 275159
6 GRAPHIC imab-ex99_1s4.jpg GRAPHIC 399805
7 GRAPHIC imab-ex99_1s5.jpg GRAPHIC 321310
8 GRAPHIC imab-ex99_1s6.jpg GRAPHIC 446536
9 GRAPHIC imab-ex99_1s7.jpg GRAPHIC 442472
10 GRAPHIC imab-ex99_1s8.jpg GRAPHIC 360786
11 GRAPHIC imab-ex99_1s9.jpg GRAPHIC 521923
12 GRAPHIC imab-ex99_1s10.jpg GRAPHIC 390705
13 GRAPHIC imab-ex99_1s11.jpg GRAPHIC 313304
14 GRAPHIC imab-ex99_1s12.jpg GRAPHIC 293432
15 GRAPHIC imab-ex99_1s13.jpg GRAPHIC 282982
16 GRAPHIC imab-ex99_1s14.jpg GRAPHIC 278063
17 GRAPHIC imab-ex99_1s15.jpg GRAPHIC 263887
18 GRAPHIC imab-ex99_1s16.jpg GRAPHIC 350605
19 GRAPHIC imab-ex99_1s17.jpg GRAPHIC 436368
20 GRAPHIC imab-ex99_1s18.jpg GRAPHIC 304571
21 GRAPHIC imab-ex99_1s19.jpg GRAPHIC 312902
22 GRAPHIC imab-ex99_1s20.jpg GRAPHIC 385753
23 GRAPHIC imab-ex99_1s21.jpg GRAPHIC 251146
24 GRAPHIC imab-ex99_1s22.jpg GRAPHIC 342364
25 GRAPHIC imab-ex99_1s23.jpg GRAPHIC 298583
26 GRAPHIC imab-ex99_1s24.jpg GRAPHIC 423605
27 GRAPHIC imab-ex99_1s25.jpg GRAPHIC 387285
28 GRAPHIC imab-ex99_1s26.jpg GRAPHIC 359012
29 GRAPHIC imab-ex99_1s27.jpg GRAPHIC 390818
30 GRAPHIC imab-ex99_1s28.jpg GRAPHIC 198500
  Complete submission text file 0000950170-25-028336.txt   14118596
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 25672912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)